Neumora expects to share additional updates on navacaprant development program at J.P. Morgan Healthcare Conference; podium presentation Tuesday, January 14 at 8:15am PT. WATERTOW ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon ... The diagnosis of major depressive disorder is based on the patient's self-reported ...

A mental health professional familiar with cognitive remediation would be the best guide for group treatment. Do you live with major depressive disorder? Learn about the resources and protections ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

Sleep problems may be one of the first symptoms of major depressive disorder -- a serious ... the sooner you can get the treatment you need to get you back on your feet. Talk to your doctor ...

Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

Bipolar disorder ... depression but not the full five needed for a major episode. It’s also worth noting that sometimes, but not always, the euphoria of mania can feel enjoyable. Once you get ...

Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...

"In 2021, 30% of Australians with a major depressive disorder received minimally adequate treatment," Dr ... Organization's Comprehensive Mental Health Action Plan 2013–2030, which aims to ...

If you have bipolar disorder, you may experience highs, known as mania, and lows, known as depression ... about their condition and stay on a treatment plan. Healthcare professionals sometimes ...

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine ...